Carter Denise P.
SEC insider (Form 3/4/5 filer). CIK 0001958621. Chief Operating Officer at Quoin Pharmaceuticals, Ltd. (QNRX). 10 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in ASHBURN, VA.
Companies Carter Denise P. has filed insider reports for
- Quoin Pharmaceuticals, Ltd. (QNRX): Director, Officer, Chief Operating Officer
Carter Denise P.
CIK: 0001958621
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Quoin Pharmaceuticals, Ltd.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Aug 31, 2026QNRX
Quoin Pharmaceuticals, Ltd.
PurchaseDirect20.5K shares at avg. $4.88$100K - Feb 4, 2026QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
318.8K shares- - May 29, 2025QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
42.9K shares- - May 29, 2025QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
42K shares- - Dec 23, 2024QNRX
Quoin Pharmaceuticals, Ltd.
PurchaseDirect555.6K shares at avg. $0.45$250K - Dec 9, 2024QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
536.6K shares- - Sep 4, 2024QNRX
Quoin Pharmaceuticals, Ltd.
PurchaseDirect23K shares at avg. $0.80$18K - Sep 4, 2024QNRX
Quoin Pharmaceuticals, Ltd.
PurchaseDirect8.8K shares at avg. $0.75$7K - Sep 3, 2024QNRX
Quoin Pharmaceuticals, Ltd.
PurchaseDirect4.1K shares at avg. $0.66$3K - Sep 3, 2024QNRX
Quoin Pharmaceuticals, Ltd.
PurchaseDirect1.8K shares at avg. $0.63$1K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | Purchase | 20,490 | $4.88 | $99,991 | Direct |
| Feb 4, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | Award Share Option (Right to Buy) | 318,750 | - | - | Direct |
| May 29, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | Award Share Option (Right to Buy) | 42,857 | - | - | Direct |
| May 29, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | Award Share Option (Right to Buy) | 42,039 | - | - | Direct |
| Dec 23, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | Purchase | 555,556 | $0.45 | $250,000 | Direct |
| Dec 9, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | Award Share Option (Right to Buy) | 536,609 | - | - | Direct |
| Sep 4, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | Purchase | 22,988 | $0.80 | $18,310 | Direct |
| Sep 4, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | Purchase | 8,825 | $0.75 | $6,602 | Direct |
| Sep 3, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | Purchase | 4,100 | $0.66 | $2,686 | Direct |
| Sep 3, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | Purchase | 1,822 | $0.63 | $1,139 | Direct |
1-10 of 10 transactions